Quantification of perivascular adipose tissue attenuation does not add incremental prognostic value in patients undergoing transcatheter aortic valve implantation
Year: 2025
Type: article
Study design: Observational Study
Abstract: Aims: Perivascular adipose tissue attenuation (PVAT) has emerged as a novel coronary computed tomography angiography (CCTA)-based biomarker predicting cardiovascular events by capturing inflammation around the coronary arteries. We assessed whether PVAT adds incremental prognostic value in patients undergoing transcatheter aortic valve implantation (TAVI). Conclusion: Measuring PVAT around either the right coronary artery or the aortic valve does not provide additional prognostic value beyond established risk factors for the prediction of MACE in patients undergoing TAVI.
DOI: 10.5167/uzh-282811
Authors: Donà, Carolina, Pavo, Noemi, Vinzens, Adriana, Gebert, Pimrapat, Beitzke, Dietrich, Reider, Lukas, Mikail, Nidaa, Rossi, Alexia, Mascherbauer, Katharina, Bengs, Susan, Haider, Achi, Buechel, Ronny R, Bartko, Philipp E, Loewe, Christian, Mascherbauer, Julia, Hengstenberg, Christian, Goliasch, Georg, Winter, Max Paul, Gebhard, Catherine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7124699174
FWCI:
Cites:
Cited by:
Related to:
